There are currently 32 ongoing clinical trials involving Meningioma
Of the 32 trials,19 trials are in Phase II
Furthermore, 7 trials are in Phase I
The global pharmaceutical industry is steadily developing new drugs for Meningioma, an Oncology disorder. The largest number of ongoing clinical trials for Meningioma is conducted in North America. Asia-Pacific and Europe are among some of the other prominent regions engaged in Meningioma -related drug trials.
Keio University School of Medicine: The leading ongoing Meningioma related clinical trial sponsor
Keio University School of Medicine is the top sponsor for Meningioma-related ongoing clinical trials.
Beijing Tiantan Hospital Capital Medical University, University of Iowa, and Massachusetts General Hospital are among other notable clinical trial sponsors involved in Meningioma. A clinical trial sponsor can be a Company, Government, Individual, or Institution.
United States of America
China
Switzerland
United States of America
United States of America
United States of America
United States of America
Germany
France
Switzerland
Don’t wait - discover a universe of connected data & insights with your next search. Browse over 28M data points across 22 industries.
Access more premium companies when you subscribe to Explorer